Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Fighting the GLP-1 Slump Some people experience an energy slump on GLP-1s
Patients should follow standard age- and risk-appropriate cancer screening guidelines from the US Preventive Services Task Force regardless of tirzepatide use
GLP-1 receptor agonists and multi-organ risk: A retrospective cohort study
Semaglutides Cardiovascular Profile Semaglutide has proven cardiovascular benefits: Demonstrated protection: SELECT trial: 20% reduction in major cardiovascular events (heart attack, stroke, cardiovascular death) SUSTAIN-6: 26% reduction in cardiovascular events in diabetic patients Blood pressure effect: Typically reduces systolic blood pressure by 4-6 mmHg Modest heart rate increase (2-4 bpm) but offset by overall protection Appropriate for: Patients with established cardiovascular disease Those with high cardiovascular risk factors Patients who would benefit from cardiovascular protection Comparison For patients with cardiovascular disease or significant risk factors, semaglutide is the clearly preferred option
US$ 21.47
US$ 27.95
US$ 25.26
US$ 24.88
US$ 28.18
US$ 27.81
US$ 28.72
US$ 24.06
US$ 21.99
